Latest Taysha Gene Therapies News & Updates

See the latest news and media coverage for Taysha. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Taysha Gene Therapies (Taysha)

Gene therapy company for CNS monogenic diseases

tayshagtx.com
Headquarters
Dallas, United States
Founded year
2020
Company type
Public company
Number of employees
125–200

Last updated

Latest news about Taysha Gene Therapies (Taysha)

In short: Taysha completed dosing in the REVEAL pivotal trial for its Rett syndrome gene therapy and priced a $200 million public offering.

Company announcements

Taysha

Taysha presents new preclinical data supporting TSHA-102 design

The data show scAAV9 yields 30-fold higher MeCP2 expression and miniMeCP2 is functionally comparable to full-length MeCP2.

Unlock all announcements with a

Media coverage

Markets Insider

Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Jefferies, Goldman Sachs & Co. LLC, Piper Sandler and Cantor are acting as joint book-running managers for the proposed offering. Baird is acting as lead...

Unlock all articles with a

Never miss news about Taysha

Track Taysha and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Taysha competitors & trending companies

Browse news for competitors to Taysha and other trending companies.